학술논문
Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma.
Document Type
Article
Source
Investigational New Drugs; Jun2013, Vol. 31 Issue 3, p769-773, 5p
Subject
Language
ISSN
01676997